08:19 AM EDT, 04/03/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally lower.

Vanda Pharmaceuticals ( VNDA ) shares were up over 25% after the company said overnight its antipsychotic agent Fanapt has been approved by the US Food and Drug Administration for the acute treatment of bipolar I disorder patients with manic or mixed episodes.